| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly oncology, and may be applied in treating lung cancer. In an operation room, immediately before the introduction to general anaesthesia, blood is taken from a patient suffering lung cancer in the amount of 200-300 ml is a sterile container with a haemo-preserving agent and separated; cell mass is selected and combined with carboplatin 150 mg/m2 and etoposide 100 mg/m2 in a first bottle. Formed plasma is combined with rhoncoleukin 1 mil. IU, incubated at 37C for 30 minutes in a second bottle. It is followed by the intravenous drop-by-drop introduction of the content of the first bottle, and then of the second bottle. The lung operation for the removal of a malignant growth is completed conventionally. ^ EFFECT: method allows avoiding side toxic responses on the introduction of the cytostatics, performing the one-stage operating removal of the malignant growth with the introduction of the anti-cancer preparations and improving body resistance, preventing postoperative complications. ^ 4 tbl, 1 ex |
